BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15287938)

  • 21. Pulmonary arterial hypertension after splenectomy for hereditary spherocytosis.
    Smedema JP; Louw VJ
    Cardiovasc J Afr; 2007; 18(2):84-9. PubMed ID: 17497044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Megaloblastic anemia due to folate deficiency associated with hereditary spherocytosis].
    Mori H; Takahashi N; Tada J; Higuchi T; Shimizu T; Harada H; Maeda T; Miyoshi Y; Okada S; Niikura H
    Rinsho Ketsueki; 1994 Apr; 35(4):397-402. PubMed ID: 8028187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness of partial splenectomy in the treatment of hereditary spherocytosis].
    Pavón Morán V; Estrada del Cueto M; Fernández Delgado N; Sánchez Damas M; Vergara Rivero R; González Otero A; Vilorio Barreras P; Svarch E
    Rev Invest Clin; 2000; 52(3):229-33. PubMed ID: 10953604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relation between types of erythrocyte membrane defects and the clinical picture in hereditary spherocytosis].
    Brabec V; Palek J; Petrtýlová K; Cermák J; Jarolím P
    Vnitr Lek; 1997 Feb; 43(2):91-4. PubMed ID: 9245075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin levels in the different clinical forms of hereditary spherocytosis.
    Rocha S; Costa E; Catarino C; Belo L; Castro EM; Barbot J; Quintanilha A; Santos-Silva A
    Br J Haematol; 2005 Nov; 131(4):534-42. PubMed ID: 16281946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary spherocytosis: Retrospective evaluation of 65 children.
    Güngör A; Yaralı N; Fettah A; Ok-Bozkaya İ; Özbek N; Kara A
    Turk J Pediatr; 2018; 60(3):264-269. PubMed ID: 30511538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematologically important mutations: ankyrin variants in hereditary spherocytosis.
    Gallagher PG
    Blood Cells Mol Dis; 2005; 35(3):345-7. PubMed ID: 16223590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-phenotype correlation in children with hereditary spherocytosis.
    Tole S; Dhir P; Pugi J; Drury LJ; Butchart S; Fantauzzi M; Langer JC; Baker JM; Blanchette VS; Kirby-Allen M; Carcao MD
    Br J Haematol; 2020 Nov; 191(3):486-496. PubMed ID: 32436265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect.
    Mariani M; Barcellini W; Vercellati C; Marcello AP; Fermo E; Pedotti P; Boschetti C; Zanella A
    Haematologica; 2008 Sep; 93(9):1310-7. PubMed ID: 18641031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiologically important secondary modifications of red cell membrane in hereditary spherocytosis-evidence for in vivo oxidation and lipid rafts protein variations.
    Margetis P; Antonelou M; Karababa F; Loutradi A; Margaritis L; Papassideri I
    Blood Cells Mol Dis; 2007; 38(3):210-20. PubMed ID: 17208471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial splenic embolization in children with hereditary spherocytosis.
    Pratl B; Benesch M; Lackner H; Portugaller HR; Pusswald B; Sovinz P; Schwinger W; Moser A; Urban C
    Eur J Haematol; 2008 Jan; 80(1):76-80. PubMed ID: 18028435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microspherocytosis. Erythroid profile and its relation with different laboratory tests].
    Aixála MT; Sarandría CN
    Medicina (B Aires); 2001; 61(4):417-23. PubMed ID: 11563170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory markers of thrombosis risk in children with hereditary spherocytosis.
    Troendle SB; Adix L; Crary SE; Buchanan GR
    Pediatr Blood Cancer; 2007 Nov; 49(6):781-5. PubMed ID: 17854065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disorders of red cell membrane.
    An X; Mohandas N
    Br J Haematol; 2008 May; 141(3):367-75. PubMed ID: 18341630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Embolisation of the splenic artery as an alternative to splenectomy for treating hereditary spherocytosis.
    Hołowiecki J; Jarczok K; Wawrzynek Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):913-6. PubMed ID: 6200404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic partial vs total splenectomy in children with hereditary spherocytosis.
    Morinis J; Dutta S; Blanchette V; Butchart S; Langer JC
    J Pediatr Surg; 2008 Sep; 43(9):1649-52. PubMed ID: 18779001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary spherocytosis: from clinical to molecular defects.
    Iolascon A; Miraglia del Giudice E; Perrotta S; Alloisio N; Morlé L; Delaunay J
    Haematologica; 1998 Mar; 83(3):240-57. PubMed ID: 9573679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risks and benefits of splenectomy versus no splenectomy for hereditary spherocytosis--a personal view.
    Schilling RF
    Br J Haematol; 2009 Jun; 145(6):728-32. PubMed ID: 19388926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary spherocytosis.
    Shah S; Vega R
    Pediatr Rev; 2004 May; 25(5):168-72. PubMed ID: 15121908
    [No Abstract]   [Full Text] [Related]  

  • 40. Splenectomy in mild hereditary spherocytosis: is it worth the risk?
    Manno CS; Cohen AR
    Am J Pediatr Hematol Oncol; 1989; 11(3):300-3. PubMed ID: 2782557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.